Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER

por LeWitt, Peter A., Boroojerdi, Babak, Surmann, Erwin, Poewe, Werner
Publicado 2012

Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease

por Hauser, Robert A, Slawek, Jaroslaw, Barone, Paolo, Dohin, Elisabeth, Surmann, Erwin, Asgharnejad, Mahnaz, Bauer, Lars
Publicado 2016

Rotigotine transdermal system and evaluation of pain in patients with Parkinson’s disease: a post hoc analysis of the RECOVER study

por Kassubek, Jan, Chaudhuri, Kallol Ray, Zesiewicz, Theresa, Surmann, Erwin, Boroojerdi, Babak, Moran, Kimberly, Ghys, Liesbet, Trenkwalder, Claudia
Publicado 2014

Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER)

por Trenkwalder, Claudia, Kies, Bryan, Rudzinska, Monika, Fine, Jennifer, Nikl, Janos, Honczarenko, Krystyna, Dioszeghy, Peter, Hill, Dennis, Anderson, Tim, Myllyla, Vilho, Kassubek, Jan, Steiger, Malcolm, Zucconi, Marco, Tolosa, Eduardo, Poewe, Werner, Surmann, Erwin, Whitesides, John, Boroojerdi, Babak, Chaudhuri, Kallol Ray
Publicado 2011